University of Lille Nord de France, F-59000, Lille, France.
Chirality. 2011 May;23(5):389-96. doi: 10.1002/chir.20939. Epub 2011 Mar 23.
The development of high-performance liquid chromatography (HPLC) methods using derivatized amylose chiral stationary phases has permitted preparative enantioseparations of substituted 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives with satisfactory yields. These compounds constitute new potent selective agonists of the cannabinoid CB(2) receptor. Analytical enantioseparation methods using UV detection were validated to determine the enantiomeric purity of these compounds. Linear calibration curves in the range from 0.18 to 0.40 mM were obtained; repeatability, limits of detection (LOD), and quantification (LOQ) were determined: LOD varied, for the various solutes, from 0.5 to 1.2 μM. All the separated compounds were prepared with high enantiomeric purities superior to 99.3% Absolute configuration of the enantiomers was unequivocally established by single crystal X-ray diffraction method and correlated to the chiroptical properties of isolated enantiomers.
采用衍生化直链淀粉手性固定相的高效液相色谱(HPLC)方法的发展,允许取代的 4-氧代-1,4-二氢喹啉-3-甲酰胺衍生物的制备对映体分离,收率令人满意。这些化合物构成了新型有效的大麻素 CB(2)受体选择性激动剂。使用紫外检测对分析对映体分离方法进行了验证,以确定这些化合物的对映体纯度。在线性范围内从 0.18 到 0.40mM 得到校准曲线; 重复性、检测限 (LOD) 和定量限 (LOQ) 确定:对于各种溶质,LOD 从 0.5 到 1.2μM 不等。所有分离的化合物均具有高于 99.3%的高对映体纯度。通过单晶 X 射线衍射方法确定对映体的绝对构型,并与分离对映体的手性光学性质相关联。